Company Profile (AI Text) Name: Cor Canonical URL: https://wefunder.com/cor Updated at: 2026-06-22T05:03:30Z Tagline: AN EXCEPTIONAL LIFE BEGINS WITH EXCEPTIONAL DATA Elevator pitch: COR is an in-home hardware and SAAS solution that measures 21-day blood response to food and exercise for longevity and life improvement Key claims: - Total raised on Wefunder: 78640 | citation: https://wefunder.com/cor#claim-total-raised - Total investors: 73 | citation: https://wefunder.com/cor#claim-total-investors Verified facts: - Total raised on Wefunder: 78640 | observed_at: 2026-06-22T05:03:30Z | expires_at: 2026-06-23T05:03:30Z - Total investors: 73 | observed_at: 2026-06-22T05:03:30Z | expires_at: 2026-06-23T05:03:30Z Computed metrics: - total_amount_raised: 78640 - total_investors: 73 - team_size: 6 - featured_investor_count: 1 - faq_count: 5 - recent_post_count: 0 Quick facts: - πŸ’ͺ 600 spectrometers deployed to date. | citation: https://wefunder.com/cor#claim-fact-1 - πŸš€ 3000+ person waitlist. | citation: https://wefunder.com/cor#claim-fact-2 - πŸ’° $3M+ revenue pace as of Dec 2021. | citation: https://wefunder.com/cor#claim-fact-3 - πŸ’Έ $12M+ raised in 2018 and 2019-2020. | citation: https://wefunder.com/cor#claim-fact-4 - πŸ“£ VC investors include Khosla Ventures, Founders Fund, West Ventures, Bellamack Partners, and more! | citation: https://wefunder.com/cor#claim-fact-5 - πŸ†World class leadership team from Apple, Stanford, and Sandia National Labs. | citation: https://wefunder.com/cor#claim-fact-6 - ⌚ Team’s track record includes bringing the Apple Watch health sensors to market. | citation: https://wefunder.com/cor#claim-fact-7 - πŸ† IRB-approved research study COR.Relate completed with 250 participants. | citation: https://wefunder.com/cor#claim-fact-8 FAQ: - Q: What validation and or certification of the blood testing hardware in terms of accuracy has been performed and or is slated to be performed? A: Thanks for asking! We have completed the COR.relate study, an IRB-approved research study and published the initial findings on the medRxiv preprint server. Research and validation are two of the cornerstones of our company. - Q: Any plans in expanding for Android operating system? A: Android is on the roadmap but I don't have a date for you yet. Thanks for your interest! - Q: Hello, can I check when you launched this campaign on WF, and also if there were early bird terms offered, and if yes, what they were. Thank you A: Hi! We've been live for a few weeks now, and no there were not early bird terms. Our SAFE has MFN so everybody gets the same deal. Thank you for your interest! - Q: I have to say I am a bit skeptical seeing as this reminds me of Theranos. Can you elaborate more on how it works? A: Hi Calvin, the output of the COR is your level of response to nutrition and fitness strategies and so there is nothing diagnostic being measured or reported. Purely information aiming to show that variability of response to validated nutrition and fitness strategies, as seen in the spectroscopy of blood. Happy to give you a deeper dive at any time! - Q: How are you going to validate these experimental blood assays/tests and get them FDA-approved for consumer use outside of the study? Are you measuring biomarkers or genetic markers too? What biomarkers are you reporting on and/or genetic markers? Are they cardio-metabolic assa... A: Hi, reiterating what I wrote just below, the output of the COR is your level of response to nutrition and fitness strategies and so there is nothing diagnostic being measured or reported. Purely information aiming to show that variability of response to validated nutrition and fitness strategies, as seen in the spectroscopy of blood. Happy to give you a deeper dive at any time!